Table 3. Relationship between LAAV and other variables.
| Variables | Correlation coefficient (r) | P value |
|---|---|---|
| Sex (male) | 0.078 | 0.323 |
| Age (years) | −0.198 | 0.011* |
| BMI (kg/m2) | 0.07 | 0.372 |
| AF duration (months) | −0.081 | 0.303 |
| CHA2DS2-VASc score | −0.25 | 0.001** |
| HAS-BLED score | −0.185 | 0.017* |
| NT-proBNP | −0.125 | 0.006** |
| UA (ìmol/L) | 0.005 | 0.947 |
| LVD (mm) | −0.017 | 0.831 |
| LAD (mm) | −0.221 | 0.004** |
| LVEF (%) | 0.21 | 0.007** |
*, P<0.05; **, P<0.01. LAAV, left atrial appendage peak flow velocity; BMI, body mass index; AF, atrial fibrillation; CHA2DS2-VASc, Congestive Heart Failure, Hypertension, Age ≥75 years [doubled], Diabetes Mellitus, Stroke [doubled], Vascular Disease, Age (65–74 years), Sex category [female]; HAS-BLED, elderly, history of hypertension, history of abnormal renal or liver function, history of stroke, history of major bleeding, medication use predisposing to bleeding, alcohol use, Labile international normalized ratio; NT-proBNP, N-terminal pro-brain natriuretic peptide; UA, uric acid; LVD, left ventricular diameter; LAD, left atrial diameter; LVEF, left ventricular ejection fraction.